Replies to post #127269 on Biotech Values

[mcbio]

I didn’t include LLY and AZN in the discussion in #msg-66670134 because neither company has expressed an interest in the FoB arena, as far as I know.

It just seems strange they wouldn't have an interest. FoBs represent a large opportunity; I wonder why they wouldn't want to participate.

[jq1234]

Both have to certain degree, but just not as loud as others. FT had stories about AZN and LLY interest in FoB awhile ago.